Another Look at Applications Submitted During the Pandemic (Part 5): A Focus on Career Stage

June 28, 2022

In earlier posts, we looked at the distributions of gender and race of designated principal investigators (PIs) of R01 and RPG applications submitted before and after the onset of the COVID-19 pandemic. Here we extend on our prior analyses by presenting R01-equivalent application data on PI characteristics of Early Stage Investigators (ESIs).

Inequalities in the Distribution of National Institutes of Health Research Project Grant Funding

January 18, 2022

This past September, my colleague and I published a paper in the journal eLife on inequalities in the support of scientists designated as Principal Investigators (PIs) of NIH Research Project Grant (RPG) awards. We found that funding inequality among PIs has increased over the past 25 years, but may have decreased modestly in more recent years. We also found greater levels of inequality across organizations.

Long-Term Trends in the Age of Principal Investigators Supported for the First Time on NIH R01-Equivalent Awards

November 18, 2021

The R01 (or R01-equivalent) grant has traditionally been a critical component to the launch of one’s research career. A number of academic leaders have described and expressed concerns about the age at which scientists are first supported on an R01 award (“age at first R01”). The biomedical research workforce is aging over the past several decades due to demographic trends and the end of mandatory retirement in academia. Here we present data from fiscal years 1995 to 2020 on age at first R01-equivalent grant.

Data on Implementing NIH’s Next Generation Researchers Initiative

July 12, 2021

Since launching in 2017, NIH’s Next Generation Researchers Initiative (NGRI) is continuing to address longstanding challenges faced by researchers trying to embark upon and sustain independent research careers as well as to promote the stability and diversity of the biomedical research workforce. Today, we are sharing data on our progress towards increased support for ESIs and other targeted groups.